Session Type
Meeting
Search Results for Copd
Oral Presentations
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of hospital readmissions in America. Over one-third of patients admitted for COPD exacerbations are readmitted within 90 days, with readmissions costing $15 billion. Medicare instituted financial penalties for excessive readmissions after COPD hospitalizations, incentivizing the creation of readmission prediction tools. Two such tools, the […]
Oral Presentations
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of hospital readmissions in America. Over one-third of patients admitted for COPD exacerbations are readmitted within 90 days, with readmissions costing $15 billion. Medicare instituted financial penalties for excessive readmissions after COPD hospitalizations, incentivizing the creation of readmission prediction tools. Two such tools, the […]
Abstract Number: 127
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Revefenacin (REV), a once-daily, long-acting muscarinic antagonist for nebulized inhalation, was recently approved for maintenance treatment of chronic obstructive pulmonary disease (COPD). We present post hoc efficacy and safety data from three phase 3 trials in patients with moderate to very severe COPD by patient subgroup (<65 y, 65–75 y, >75 y). Methods: This […]
Abstract Number: 128
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Many patients with chronic obstructive pulmonary disease (COPD) have suboptimal peak inspiratory flow rate (sPIFR) because of lung hyperinflation, hypoxemia, and muscle wasting, preventing effective use of dry powder inhalers commonly used to treat COPD. sPIFR and airflow limitation interaction may be responsible for excess symptoms in patients with COPD. Here we characterize baseline […]
Abstract Number: 178
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Hospital Readmission Reduction Program(HRRP) implemented by CMS as part of Affordable Care Act (ACA) applies financial penalties to hospitals that have higher-than-expected readmission rates for common conditions such as AMI, pneumonia, and HF. CMS extended this program to include COPD for the fiscal year (FY) 2015. While there has been a reduction in readmissions, […]